Cover Image
市場調查報告書

北美的心律管理設備市場未來展望

North America Cardiac Rhythm Management Devices Market Outlook to 2021

出版商 GlobalData 商品編碼 357516
出版日期 內容資訊 英文 206 Pages
訂單完成後即時交付
價格
Back to Top
北美的心律管理設備市場未來展望 North America Cardiac Rhythm Management Devices Market Outlook to 2021
出版日期: 2016年02月05日 內容資訊: 英文 206 Pages
簡介

本報告提供北美各國 (美國·加拿大·墨西哥) 的心律管理 (CRM) 設備的市場相關分析,提供您地區整體市場趨勢的轉變和預測 (過去·今後8年份),各國水準之詳細趨勢,主要企業·流通管道的市場佔有率,主要的開發中產品之目前臨床實驗情形,近來的市場趨勢,主要企業簡介等調查評估。

第1章 目錄

第2章 簡介

  • 本報告概要
  • 心律管理 (CRM) 設備市場明細
  • 本報告分析對象市場定義

第3章 北美的心律管理設備市場

  • 市場收益額:以金額為準 (總計15年份)
  • 市場收益額:不同分類的比較 (總計15年份)
  • 市場收益額的實際成果值:以金額為準 (過去8年份)
  • 市場收益額的預測值:以金額為準 (今後8年份)
  • 市場規模:以數量為準 (總計15年份)
  • 市場規模的實際成果值:以數量為準 (過去8年份)
  • 市場規模的預測值:以數量為準 (今後8年份)
  • 市場收益額佔有率:各企業

第4章 加拿大的心律管理設備市場

  • 市場收益額的實際成果值:以金額為準 (過去8年份)
  • 市場收益額的預測值:以金額為準 (今後8年份)
    • 置入式除顫器 (ICD):市場收益額的實際成果值 (過去8年份)
    • 心律調節器:市場收益額的實際成果值 (過去8年份)
    • 心臟再同步治療 (CRT):市場收益額的實際成果值 (過去8年份)
    • 置入式除顫器 (ICD):市場收益額的預測值 (今後8年份)
    • 心律調節器:市場收益額的預測值 (今後8年份)
    • 心臟再同步治療 (CRT):市場收益額的預測值 (今後8年份)
  • 市場規模的實際成果值:以數量為準 (過去8年份)
  • 市場規模的預測值:以數量為準 (今後8年份)
    • 置入式除顫器 (ICD):市場規模的實際成果值 (過去8年份)
    • 心律調節器:市場規模的實際成果值 (過去8年份)
    • 心臟再同步治療 (CRT):市場規模的實際成果值 (過去8年份)
    • 置入式除顫器 (ICD):市場規模的預測值 (今後8年份)
    • 心律調節器:市場規模的預測值 (今後8年份)
    • 心臟再同步治療 (CRT):市場規模的預測值 (今後8年份)
  • 平均價格趨勢·預測 (總計15年份)
  • 市場收益額佔有率:各流通管道
  • 市場收益額佔有率:各企業

第5章 墨西哥的心律管理設備市場

第6章 美國的心律管理設備市場

第7章 主要企業概要:北美的心律管理設備市場

  • Medtronic plc
  • St. Jude Medical, Inc.
  • Boston Scientific Corporation
  • Biotronik SE & Co. KG

第8章 心律管理設備市場開發中產品

第9章 近幾年的市場趨勢

  • 來自企業的發表 (corporate·通訊) (全16件)
  • 公佈財報 (全21件)
  • 政府·公益相關 (1件)
  • 法規·規定相關 (全5件)
  • 其他主要動向 (全4件)
  • 產品新聞 (1件)
  • 策略·產業計畫 (全2件)

第10章 附錄

圖表一覽

目錄
Product Code: GDMECR0382DB

GlobalData's new report, North America Cardiac Rhythm Management Devices Market Outlook to 2021, provides key market data on the North America Cardiac Rhythm Management Devices market. The report provides value, in millions of US dollars, volume (in units) and average price data (in US dollars), within market segments - Cardiac Resynchronisation Therapy (CRT), Implantable Cardioverter Defibrillators (ICD), Implantable Loop Recorders (ILR) and Pacemakers.

The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and countries in the region, information related to pipeline products, news and deals is available in the report.

The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible.

The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers.

Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases).

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

  • Market size for Cardiac Rhythm Management Devices market segments - Cardiac Resynchronisation Therapy (CRT), Implantable Cardioverter Defibrillators (ICD), Implantable Loop Recorders (ILR) and Pacemakers.
  • Annualized market revenues (USD million), volume (units) and average selling price ($) data for each of the market categories. Data is provided from 2007 to 2014 and forecast to 2021.
  • 2014 company shares and distribution shares data for Cardiac Rhythm Management Devices market.
  • Global corporate-level profiles of key companies operating within the North America Cardiac Rhythm Management Devices market.
  • Key players covered include Medtronic plc, St. Jude Medical, Inc., Boston Scientific Corporation and Others.

Reasons to buy

  • Develop business strategies by identifying the key market segments poised for strong growth in the future.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. What Is This Report About?
  • 2.2. Cardiac Rhythm Management Devices Market Segmentation
  • 2.3. Definitions of Markets Covered in the Report

3. Cardiac Rhythm Management Devices Market, North America

  • 3.1. Cardiac Rhythm Management Devices Market, North America, Revenue ($m), 2007-2021
  • 3.2. Cardiac Rhythm Management Devices Market, North America, Category Comparison by Revenue ($m), 2007-2021
  • 3.3. Cardiac Rhythm Management Devices Market, North America, Revenue ($m), 2007-2014
  • 3.4. Cardiac Rhythm Management Devices Market, North America, Revenue ($m), 2014-2021
  • 3.5. Cardiac Rhythm Management Devices Market, North America, Volume (Units), 2007-2021
  • 3.6. Cardiac Rhythm Management Devices Market, North America, Volume (Units), 2007-2014
  • 3.7. Cardiac Rhythm Management Devices Market, North America, Volume (Units), 2014-2021
  • 3.8. Cardiac Rhythm Management Devices Market, North America, Company Share by Revenue ($m), 2014

4. Cardiac Rhythm Management Devices Market, Canada

  • 4.1. Cardiac Rhythm Management Devices Market, Canada, Revenue ($m), 2007-2014
  • 4.2. Cardiac Rhythm Management Devices Market, Canada, Revenue ($m), 2014-2021
    • 4.2.1. Cardiac Resynchronisation Therapy (CRT) Market, Canada, Revenue ($m), by Segment, 2007-2014
    • 4.2.2. Implantable Cardioverter Defibrillators (ICD) Market, Canada, Revenue ($m), by Segment, 2007-2014
    • 4.2.3. Pacemakers Market, Canada, Revenue ($m), by Segment, 2007-2014
    • 4.2.4. Cardiac Resynchronisation Therapy (CRT) Market, Canada, Revenue ($m), by Segment, 2014-2021
    • 4.2.5. Implantable Cardioverter Defibrillators (ICD) Market, Canada, Revenue ($m), by Segment, 2014-2021
    • 4.2.6. Pacemakers Market, Canada, Revenue ($m), by Segment, 2014-2021
  • 4.3. Cardiac Rhythm Management Devices Market, Canada, Volume (Units), 2007-2014
  • 4.4. Cardiac Rhythm Management Devices Market, Canada, Volume (Units), 2014-2021
    • 4.4.1. Cardiac Resynchronisation Therapy (CRT) Market, Canada, Volume (Units), by Segment, 2007-2014
    • 4.4.2. Implantable Cardioverter Defibrillators (ICD) Market, Canada, Volume (Units), by Segment, 2007-2014
    • 4.4.3. Pacemakers Market, Canada, Volume (Units), by Segment, 2007-2014
    • 4.4.4. Cardiac Resynchronisation Therapy (CRT) Market, Canada, Volume (Units), by Segment, 2014-2021
    • 4.4.5. Implantable Cardioverter Defibrillators (ICD) Market, Canada, Volume (Units), by Segment, 2014-2021
    • 4.4.6. Pacemakers Market, Canada, Volume (Units), by Segment, 2014-2021
  • 4.5. Cardiac Rhythm Management Devices Market, Canada, Average Price ($), 2007-2021
  • 4.6. Cardiac Rhythm Management Devices Market, Canada, Distribution Share by Revenue ($m), 2013-2014
  • 4.7. Cardiac Rhythm Management Devices Market, Canada, Company Share by Revenue ($m), 2014

5. Cardiac Rhythm Management Devices Market, Mexico

  • 5.1. Cardiac Rhythm Management Devices Market, Mexico, Revenue ($m), 2007-2014
  • 5.2. Cardiac Rhythm Management Devices Market, Mexico, Revenue ($m), 2014-2021
    • 5.2.1. Cardiac Resynchronisation Therapy (CRT) Market, Mexico, Revenue ($m), by Segment, 2007-2014
    • 5.2.2. Implantable Cardioverter Defibrillators (ICD) Market, Mexico, Revenue ($m), by Segment, 2007-2014
    • 5.2.3. Pacemakers Market, Mexico, Revenue ($m), by Segment, 2007-2014
    • 5.2.4. Cardiac Resynchronisation Therapy (CRT) Market, Mexico, Revenue ($m), by Segment, 2014-2021
    • 5.2.5. Implantable Cardioverter Defibrillators (ICD) Market, Mexico, Revenue ($m), by Segment, 2014-2021
    • 5.2.6. Pacemakers Market, Mexico, Revenue ($m), by Segment, 2014-2021
  • 5.3. Cardiac Rhythm Management Devices Market, Mexico, Volume (Units), 2007-2014
  • 5.4. Cardiac Rhythm Management Devices Market, Mexico, Volume (Units), 2014-2021
    • 5.4.1. Cardiac Resynchronisation Therapy (CRT) Market, Mexico, Volume (Units), by Segment, 2007-2014
    • 5.4.2. Implantable Cardioverter Defibrillators (ICD) Market, Mexico, Volume (Units), by Segment, 2007-2014
    • 5.4.3. Pacemakers Market, Mexico, Volume (Units), by Segment, 2007-2014
    • 5.4.4. Cardiac Resynchronisation Therapy (CRT) Market, Mexico, Volume (Units), by Segment, 2014-2021
    • 5.4.5. Implantable Cardioverter Defibrillators (ICD) Market, Mexico, Volume (Units), by Segment, 2014-2021
    • 5.4.6. Pacemakers Market, Mexico, Volume (Units), by Segment, 2014-2021
  • 5.5. Cardiac Rhythm Management Devices Market, Mexico, Average Price ($), 2007-2021
  • 5.6. Cardiac Rhythm Management Devices Market, Mexico, Distribution Share by Revenue ($m), 2013-2014
  • 5.7. Cardiac Rhythm Management Devices Market, Mexico, Company Share by Revenue ($m), 2014

6. Cardiac Rhythm Management Devices Market, United States

  • 6.1. Cardiac Rhythm Management Devices Market, United States, Revenue ($m), 2007-2014
  • 6.2. Cardiac Rhythm Management Devices Market, United States, Revenue ($m), 2014-2021
    • 6.2.1. Cardiac Resynchronisation Therapy (CRT) Market, United States, Revenue ($m), by Segment, 2007-2014
    • 6.2.2. Implantable Cardioverter Defibrillators (ICD) Market, United States, Revenue ($m), by Segment, 2007-2014
    • 6.2.3. Pacemakers Market, United States, Revenue ($m), by Segment, 2007-2014
    • 6.2.4. Cardiac Resynchronisation Therapy (CRT) Market, United States, Revenue ($m), by Segment, 2014-2021
    • 6.2.5. Implantable Cardioverter Defibrillators (ICD) Market, United States, Revenue ($m), by Segment, 2014-2021
    • 6.2.6. Pacemakers Market, United States, Revenue ($m), by Segment, 2014-2021
  • 6.3. Cardiac Rhythm Management Devices Market, United States, Volume (Units), 2007-2014
  • 6.4. Cardiac Rhythm Management Devices Market, United States, Volume (Units), 2014-2021
    • 6.4.1. Cardiac Resynchronisation Therapy (CRT) Market, United States, Volume (Units), by Segment, 2007-2014
    • 6.4.2. Implantable Cardioverter Defibrillators (ICD) Market, United States, Volume (Units), by Segment, 2007-2014
    • 6.4.3. Pacemakers Market, United States, Volume (Units), by Segment, 2007-2014
    • 6.4.4. Cardiac Resynchronisation Therapy (CRT) Market, United States, Volume (Units), by Segment, 2014-2021
    • 6.4.5. Implantable Cardioverter Defibrillators (ICD) Market, United States, Volume (Units), by Segment, 2014-2021
    • 6.4.6. Pacemakers Market, United States, Volume (Units), by Segment, 2014-2021
  • 6.5. Cardiac Rhythm Management Devices Market, United States, Average Price ($), 2007-2021
  • 6.6. Cardiac Rhythm Management Devices Market, United States, Distribution Share by Revenue ($m), 2013-2014
  • 6.7. Cardiac Rhythm Management Devices Market, United States, Company Share by Revenue ($m), 2014

7. Overview of Key Companies in North America Cardiac Rhythm Management Devices Market

  • 7.1. Medtronic plc
    • 7.1.1. Company Overview
  • 7.2. St. Jude Medical, Inc.
    • 7.2.1. Company Overview
  • 7.3. Boston Scientific Corporation
    • 7.3.1. Company Overview
  • 7.4. Biotronik SE & Co. KG
    • 7.4.1. Company Overview

8. Cardiac Rhythm Management Devices Market Pipeline Products

9. Recent Developments

  • 9.1. Corporate Communications
    • 9.1.1. Dec 22, 2015: SurModics Announces Device Veteran Shawn McCormick Joins Board of Directors
    • 9.1.2. Nov 17, 2015: Proteus Digital Health Announces New Chairman of the Board and Chief Commercial Officer
    • 9.1.3. Nov 16, 2015: Konica Minolta to Start In Vitro Diagnostics Business in European and American Markets: SPFS Immunoassay System on Reference Exhibit at MEDICA 2015. in Germany
    • 9.1.4. Nov 04, 2015: Ventripoint Announces New Director and Provides Corporate Update
    • 9.1.5. Oct 20, 2015: Cardiac Science Files Chapter 11 Petition to Facilitate Debt Restructuring
    • 9.1.6. Oct 12, 2015: Orthopaedic Associates of Wisconsin and Blue Belt Technologies Announce First Surgery Center in Wisconsin to Implement CT-Free Robotic Orthopedic Surgery
    • 9.1.7. Oct 09, 2015: Dako, an Agilent Technologies Company, Announces FDA Approval of New Test for Lung Cancer Patients
    • 9.1.8. Aug 24, 2015: Daiichi Sankyo Obtains Approval in Japan for Supplementary Indication for "Artist Tablets"
    • 9.1.9. Jul 21, 2015: iRhythm Technologies Appoints Marga Ortigas-Wedekind Executive Vice President, Global Marketing
    • 9.1.10. Jul 02, 2015: BioTek Introduces Synergy Neo2 High Performance Multi-Mode Microplate Reader
    • 9.1.11. Jun 25, 2015: Medtronic Names Geoff Martha Executive Vice President and President, Restorative Therapies Group
    • 9.1.12. May 13, 2015: iRhythm Expands Leadership Team with Appointment of Derrick Sung, Ph.D. as Executive Vice President of Global Strategy and Corporate Development
    • 9.1.13. May 04, 2015: Stereotaxis Elects Medical Device Industry Veteran Duane DeSisto to Board of Directors
    • 9.1.14. Mar 25, 2015: Ventripoint Announces Resignation of Director
    • 9.1.15. Mar 06, 2015: SurModics Announces New Board Chair
    • 9.1.16. Feb 05, 2015: SurModics Announces Gerald B. Fischer's Retirement from Board of Directors
  • 9.2. Financial Announcements
    • 9.2.1. Dec 18, 2015: BRILIQUE (ticagrelor) receives positive European Union CHMP opinion for extended treatment of patients with a history of heart attack
    • 9.2.2. Dec 18, 2015: Sarepta Therapeutics Announces FDA Advisory Committee Meeting to Review Eteplirsen as a Treatment for Duchenne Muscular Dystrophy Amenable to Exon 51. Skipping
    • 9.2.3. Nov 10, 2015: SurModics Reports Fourth Quarter Fiscal 2015 Results
    • 9.2.4. Nov 03, 2015: Orthofix International Reports Third Quarter 2015 Financial Results
    • 9.2.5. Oct 22, 2015: Bard Announces Third Quarter Results
    • 9.2.6. Oct 01, 2015: Over 2000 Patients Treated with Ellipse Technologies' MAGEC System
    • 9.2.7. Sep 30, 2015: MediWound Awarded BARDA Contract Valued Up to $112 Million for Development and Procurement of NexoBrid for the U.S.
    • 9.2.8. Aug 20, 2015: New type of trial shows promise for several cancers
    • 9.2.9. Aug 05, 2015: SurModics Reports Third Quarter Fiscal 2015 Results
    • 9.2.10. Aug 04, 2015: Stereotaxis Reports 2015 Second Quarter Financial Results
    • 9.2.11. Jul 23, 2015: Bard Announces Second Quarter Results
    • 9.2.12. Jun 02, 2015: Medtronic Reports Fourth Quarter and Fiscal Year 2015 Financial Results
    • 9.2.13. May 19, 2015: Medtronic Announces Preliminary Fourth Quarter and Fiscal Year 2015 Revenue Results
    • 9.2.14. May 06, 2015: Stereotaxis Reports 2015 First Quarter Financial Results
    • 9.2.15. Apr 30, 2015: SurModics Reports Second Quarter Fiscal 2015 Results
    • 9.2.16. Apr 23, 2015: Bard Announces First Quarter Results
    • 9.2.17. Apr 17, 2015: Bionomics Showcases BNC101 Oncology Drug Development Program at 2015 AACR Annual Meeting
    • 9.2.18. Mar 11, 2015: The Medicines Company Provides new data on MDCO-216 at 2015 American College of Cardiology Scientific Sessions in San Diego
    • 9.2.19. Feb 25, 2015: Stereotaxis Reports 2014 Fourth Quarter and Full Year Financial Results
    • 9.2.20. Jan 29, 2015: SurModics Reports First Quarter Fiscal 2015 Results
    • 9.2.21. Jan 29, 2015: Bard Announces Fourth Quarter Results
  • 9.3. Government and Public Interest
    • 9.3.1. Jul 14, 2015: Malaysia, The Hub Of Medical Device Manufacturing In Asean
  • 9.4. Legal And Regulatory
    • 9.4.1. Jan 05, 2016: LivaNova Provides Update on FDA Warning Letter
    • 9.4.2. Nov 20, 2015: Medtronic Statement on U.S. Department of Treasury's Notice 2015-79
    • 9.4.3. Jul 21, 2015: FDA Issues Warning Letter To C. R. Bard
    • 9.4.4. Apr 02, 2015: Medtronic To Pay $4.41 Million To Resolve Allegations That It Unlawfully Sold Medical Devices Manufactured Overseas
    • 9.4.5. Feb 06, 2015: Medtronic to Pay $2.8 Million to Resolve False Claims Act Allegations Related to "SubQ Stimulation" Procedures
  • 9.5. Other Significant Developments
    • 9.5.1. Jan 08, 2016: SurModics Provides Updated 2016 Guidance
    • 9.5.2. Nov 18, 2015: iRhythm Technologies Launches New iOS App Enabling Patients to Report Irregular Heartbeat Symptoms for Physician Diagnosis
    • 9.5.3. Mar 30, 2015: Ventripoint Announces Distribution Partner for Military and VA Medical Centers
    • 9.5.4. Feb 19, 2015: Helius Medical Enrols First Patients In Multiple Sclerosis Feasibility Trial Of PoNS Device
  • 9.6. Product News
    • 9.6.1. Dec 22, 2015: FDA Approves BIOTRONIK Iperia ICD Systems with Full-Body ProMRI Technology
  • 9.7. Strategy And Business Planning
    • 9.7.1. Jan 19, 2016: Leading Medical Device Companies Select Brainshark to Drive Sales Productivity
    • 9.7.2. Mar 30, 2015: Stereotaxis Extends Silicon Valley Bank Credit Facility by Three Years

10. Appendix

  • 10.1. Research Methodology
    • 10.1.1. Coverage
    • 10.1.2. Secondary Research
    • 10.1.3. Primary Research
    • 10.1.4. Market Modeling and Forecasting
    • 10.1.5. Company Share Analysis
    • 10.1.6. Distribution Share Analysis
  • 10.2. Expert Panel
  • 10.3. GlobalData Consulting
  • 10.4. Contact Us
  • 10.5. Disclaimer

List of Tables

  • Table 1: Cardiac Rhythm Management Devices Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2007-2021
  • Table 2: Cardiac Rhythm Management Devices Market, North America, Category Comparison by Revenue ($m), USD Constant, 2007-2021
  • Table 3: Cardiac Rhythm Management Devices Market, North America, Revenue ($m), Historic, USD Constant, 2007-2014
  • Table 4: Cardiac Rhythm Management Devices Market, North America, Revenue ($m), Forecast, USD Constant, 2014-2021
  • Table 5: Cardiac Rhythm Management Devices Market, North America, Volume (Units), 2007-2021
  • Table 6: Cardiac Rhythm Management Devices Market, North America, Volume (Units), Historic, 2007-2014
  • Table 7: Cardiac Rhythm Management Devices Market, North America, Volume (Units), Forecast, 2014-2021
  • Table 8: Cardiac Rhythm Management Devices Market, North America, Company Share by Revenue ($m), USD Constant, 2014
  • Table 9: Cardiac Rhythm Management Devices Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 10: Cardiac Rhythm Management Devices Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 11: Cardiac Resynchronisation Therapy (CRT) Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 12: Implantable Cardioverter Defibrillators (ICD) Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 13: Pacemakers Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 14: Cardiac Resynchronisation Therapy (CRT) Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 15: Implantable Cardioverter Defibrillators (ICD) Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 16: Pacemakers Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 17: Cardiac Rhythm Management Devices Market, Canada, Volume (Units), Historic, 2007-2014
  • Table 18: Cardiac Rhythm Management Devices Market, Canada, Volume (Units), Forecast, 2014-2021
  • Table 19: Cardiac Resynchronisation Therapy (CRT) Market, Canada, Volume (Units), Historic, 2007-2014
  • Table 20: Implantable Cardioverter Defibrillators (ICD) Market, Canada, Volume (Units), Historic, 2007-2014
  • Table 21: Pacemakers Market, Canada, Volume (Units), Historic, 2007-2014
  • Table 22: Cardiac Resynchronisation Therapy (CRT) Market, Canada, Volume (Units), Forecast, 2014-2021
  • Table 23: Implantable Cardioverter Defibrillators (ICD) Market, Canada, Volume (Units), Forecast, 2014-2021
  • Table 24: Pacemakers Market, Canada, Volume (Units), Forecast, 2014-2021
  • Table 25: Cardiac Rhythm Management Devices Market, Canada, Average Price ($) Historic, 2007-2014
  • Table 26: Cardiac Rhythm Management Devices Market, Canada, Average Price ($), Forecast, 2014-2021
  • Table 27: Cardiac Rhythm Management Devices Market, Canada, Distribution Share by Revenue ($m), USD Constant, 2013-2014
  • Table 28: Cardiac Rhythm Management Devices Market, Canada, Company Share by Revenue ($m), USD Constant, 2014
  • Table 29: Cardiac Rhythm Management Devices Market, Mexico, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 30: Cardiac Rhythm Management Devices Market, Mexico, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 31: Cardiac Resynchronisation Therapy (CRT) Market, Mexico, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 32: Implantable Cardioverter Defibrillators (ICD) Market, Mexico, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 33: Pacemakers Market, Mexico, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 34: Cardiac Resynchronisation Therapy (CRT) Market, Mexico, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 35: Implantable Cardioverter Defibrillators (ICD) Market, Mexico, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 36: Pacemakers Market, Mexico, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 37: Cardiac Rhythm Management Devices Market, Mexico, Volume (Units), Historic, 2007-2014
  • Table 38: Cardiac Rhythm Management Devices Market, Mexico, Volume (Units), Forecast, 2014-2021
  • Table 39: Cardiac Resynchronisation Therapy (CRT) Market, Mexico, Volume (Units), Historic, 2007-2014
  • Table 40: Implantable Cardioverter Defibrillators (ICD) Market, Mexico, Volume (Units), Historic, 2007-2014
  • Table 41: Pacemakers Market, Mexico, Volume (Units), Historic, 2007-2014
  • Table 42: Cardiac Resynchronisation Therapy (CRT) Market, Mexico, Volume (Units), Forecast, 2014-2021
  • Table 43: Implantable Cardioverter Defibrillators (ICD) Market, Mexico, Volume (Units), Forecast, 2014-2021
  • Table 44: Pacemakers Market, Mexico, Volume (Units), Forecast, 2014-2021
  • Table 45: Cardiac Rhythm Management Devices Market, Mexico, Average Price ($) Historic, 2007-2014
  • Table 46: Cardiac Rhythm Management Devices Market, Mexico, Average Price ($), Forecast, 2014-2021
  • Table 47: Cardiac Rhythm Management Devices Market, Mexico, Distribution Share by Revenue ($m), USD Constant, 2013-2014
  • Table 48: Cardiac Rhythm Management Devices Market, Mexico, Company Share by Revenue ($m), USD Constant, 2014
  • Table 49: Cardiac Rhythm Management Devices Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 50: Cardiac Rhythm Management Devices Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 51: Cardiac Resynchronisation Therapy (CRT) Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 52: Implantable Cardioverter Defibrillators (ICD) Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 53: Pacemakers Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 54: Cardiac Resynchronisation Therapy (CRT) Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 55: Implantable Cardioverter Defibrillators (ICD) Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 56: Pacemakers Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 57: Cardiac Rhythm Management Devices Market, United States, Volume (Units), Historic, 2007-2014
  • Table 58: Cardiac Rhythm Management Devices Market, United States, Volume (Units), Forecast, 2014-2021
  • Table 59: Cardiac Resynchronisation Therapy (CRT) Market, United States, Volume (Units), Historic, 2007-2014
  • Table 60: Implantable Cardioverter Defibrillators (ICD) Market, United States, Volume (Units), Historic, 2007-2014
  • Table 61: Pacemakers Market, United States, Volume (Units), Historic, 2007-2014
  • Table 62: Cardiac Resynchronisation Therapy (CRT) Market, United States, Volume (Units), Forecast, 2014-2021
  • Table 63: Implantable Cardioverter Defibrillators (ICD) Market, United States, Volume (Units), Forecast, 2014-2021
  • Table 64: Pacemakers Market, United States, Volume (Units), Forecast, 2014-2021
  • Table 65: Cardiac Rhythm Management Devices Market, United States, Average Price ($) Historic, 2007-2014
  • Table 66: Cardiac Rhythm Management Devices Market, United States, Average Price ($), Forecast, 2014-2021
  • Table 67: Cardiac Rhythm Management Devices Market, United States, Distribution Share by Revenue ($m), USD Constant, 2013-2014
  • Table 68: Cardiac Rhythm Management Devices Market, United States, Company Share by Revenue ($m), USD Constant, 2014
  • Table 69: Cardiac Rhythm Management Devices Market Pipeline Products
  • Table 70: Total Number of Primary Research Participants, Cardiovascular Devices Market, by Country

List of Figures

  • Figure 1: Cardiac Rhythm Management Devices Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2007-2021
  • Figure 2: Cardiac Rhythm Management Devices Market, North America, Category Comparison by Revenue ($m), USD Constant, 2007-2021
  • Figure 3: Cardiac Rhythm Management Devices Market, North America, Revenue ($m), Historic, USD Constant, 2007-2014
  • Figure 4: Cardiac Rhythm Management Devices Market, North America, Revenue ($m), Forecast, USD Constant, 2014-2021
  • Figure 5: Cardiac Rhythm Management Devices Market, North America, Volume (Units), 2007-2021
  • Figure 6: Cardiac Rhythm Management Devices Market, North America, Volume (Units), Historic, 2007-2014
  • Figure 7: Cardiac Rhythm Management Devices Market, North America, Volume (Units), Forecast, 2014-2021
  • Figure 8: Cardiac Rhythm Management Devices Market, North America, Company Share (%) 2014
  • Figure 9: Cardiac Rhythm Management Devices Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 10: Cardiac Rhythm Management Devices Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 11: Cardiac Resynchronisation Therapy (CRT) Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 12: Implantable Cardioverter Defibrillators (ICD) Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 13: Pacemakers Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 14: Cardiac Resynchronisation Therapy (CRT) Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 15: Implantable Cardioverter Defibrillators (ICD) Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 16: Pacemakers Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 17: Cardiac Rhythm Management Devices Market, Canada, Volume (Units), Historic, 2007-2014
  • Figure 18: Cardiac Rhythm Management Devices Market, Canada, Volume (Units), Forecast, 2014-2021
  • Figure 19: Cardiac Resynchronisation Therapy (CRT) Market, Canada, Volume (Units), Historic, 2007-2014
  • Figure 20: Implantable Cardioverter Defibrillators (ICD) Market, Canada, Volume (Units), Historic, 2007-2014
  • Figure 21: Pacemakers Market, Canada, Volume (Units), Historic, 2007-2014
  • Figure 22: Cardiac Resynchronisation Therapy (CRT) Market, Canada, Volume (Units), Forecast, 2014-2021
  • Figure 23: Implantable Cardioverter Defibrillators (ICD) Market, Canada, Volume (Units), Forecast, 2014-2021
  • Figure 24: Pacemakers Market, Canada, Volume (Units), Forecast, 2014-2021
  • Figure 25: Cardiac Rhythm Management Devices Market, Canada, Company Share (%) 2014
  • Figure 26: Cardiac Rhythm Management Devices Market, Mexico, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 27: Cardiac Rhythm Management Devices Market, Mexico, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 28: Cardiac Resynchronisation Therapy (CRT) Market, Mexico, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 29: Implantable Cardioverter Defibrillators (ICD) Market, Mexico, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 30: Pacemakers Market, Mexico, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 31: Cardiac Resynchronisation Therapy (CRT) Market, Mexico, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 32: Implantable Cardioverter Defibrillators (ICD) Market, Mexico, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 33: Pacemakers Market, Mexico, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 34: Cardiac Rhythm Management Devices Market, Mexico, Volume (Units), Historic, 2007-2014
  • Figure 35: Cardiac Rhythm Management Devices Market, Mexico, Volume (Units), Forecast, 2014-2021
  • Figure 36: Cardiac Resynchronisation Therapy (CRT) Market, Mexico, Volume (Units), Historic, 2007-2014
  • Figure 37: Implantable Cardioverter Defibrillators (ICD) Market, Mexico, Volume (Units), Historic, 2007-2014
  • Figure 38: Pacemakers Market, Mexico, Volume (Units), Historic, 2007-2014
  • Figure 39: Cardiac Resynchronisation Therapy (CRT) Market, Mexico, Volume (Units), Forecast, 2014-2021
  • Figure 40: Implantable Cardioverter Defibrillators (ICD) Market, Mexico, Volume (Units), Forecast, 2014-2021
  • Figure 41: Pacemakers Market, Mexico, Volume (Units), Forecast, 2014-2021
  • Figure 42: Cardiac Rhythm Management Devices Market, Mexico, Company Share (%) 2014
  • Figure 43: Cardiac Rhythm Management Devices Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 44: Cardiac Rhythm Management Devices Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 45: Cardiac Resynchronisation Therapy (CRT) Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 46: Implantable Cardioverter Defibrillators (ICD) Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 47: Pacemakers Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 48: Cardiac Resynchronisation Therapy (CRT) Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 49: Implantable Cardioverter Defibrillators (ICD) Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 50: Pacemakers Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 51: Cardiac Rhythm Management Devices Market, United States, Volume (Units), Historic, 2007-2014
  • Figure 52: Cardiac Rhythm Management Devices Market, United States, Volume (Units), Forecast, 2014-2021
  • Figure 53: Cardiac Resynchronisation Therapy (CRT) Market, United States, Volume (Units), Historic, 2007-2014
  • Figure 54: Implantable Cardioverter Defibrillators (ICD) Market, United States, Volume (Units), Historic, 2007-2014
  • Figure 55: Pacemakers Market, United States, Volume (Units), Historic, 2007-2014
  • Figure 56: Cardiac Resynchronisation Therapy (CRT) Market, United States, Volume (Units), Forecast, 2014-2021
  • Figure 57: Implantable Cardioverter Defibrillators (ICD) Market, United States, Volume (Units), Forecast, 2014-2021
  • Figure 58: Pacemakers Market, United States, Volume (Units), Forecast, 2014-2021
  • Figure 59: Cardiac Rhythm Management Devices Market, United States, Company Share (%) 2014
  • Figure 60: GlobalData Epidemiology-Based Forecasting Model
  • Figure 61: GlobalData Capital Equipment-Based Forecasting Model
  • Figure 62: Primary Interviews by Participant Type (%)
Back to Top